Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment... TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.3 | -12.7659574468 | 2.35 | 2.375 | 2.02 | 275065 | 2.10481715 | CS |
| 4 | -0.43 | -17.3387096774 | 2.48 | 2.67 | 2.02 | 234586 | 2.3431429 | CS |
| 12 | -1.89 | -47.9695431472 | 3.94 | 4.9399 | 2.02 | 425610 | 3.06845935 | CS |
| 26 | -3.82 | -65.0766609881 | 5.87 | 6.225 | 2.02 | 309990 | 3.98969706 | CS |
| 52 | -3.81 | -65.0170648464 | 5.86 | 9.69 | 2.02 | 276271 | 5.37520895 | CS |
| 156 | -2.66 | -56.4755838641 | 4.71 | 9.69 | 1.45 | 270300 | 4.17462183 | CS |
| 260 | -9.95 | -82.9166666667 | 12 | 14.71 | 1.45 | 237418 | 4.36550528 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
